MRD-Adapted Low-Dose Radiation Therapy During Frontline Chemoimmunotherapy for Diffuse Large B-Cell Lymphoma
Clinical trial NCT07517705 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07517705
- Sponsor
- University of Nebraska
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-06-12
- Primary completion
- 2030-11-12
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.